Fact CheckerSign in

NCT06377748Completed

The Effect of Facilitated-tucking and ShotBlocker on Pain Caused by Vaccination in Healthy Infants

The Effect of Facilitated-tucking, ShotBlocker, and the Combination of the Facilitated-tucking and ShotBlocker on Pain Caused by Hepatitis-B Vaccination in Healthy Term Infants: Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 16 Oct 2024

Brief summary (registry, in English)

This study will be investigated the effects of facilitated tucking, ShotBlocker and combined facilitated tucking and ShotBlocker methods on procedural pain, crying time and duration of the procedure during Hepatitis B vaccine administration in healthy term infants.

Status (registry)
Completed
Study type
Interventional
Enrollment
142 (actual)
First submitted
17 Apr 2024
Start date
15 Jun 2024
Primary completion date
30 Sept 2024
Lead sponsor
Istanbul Medeniyet University
Diseases
Hepatitis B
NCT number
NCT06377748

What you commit to

  • Study type: Interventional
  • Participants enrolled: 142
  • From 15 Jun 2024 to the primary completion date, 30 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • neurological, cardiological and metabolic diseases,
  • acute or chronic illness that causes pain,
  • infants of hepatitis B carrier mothers,
  • infants of mothers with a history of substance abuse

Other

  • With a genetic or congenital anomaly,
  • in need of respiratory support,
  • a complication of childbirth,
  • nerve damage or deformity in the extremity to be vaccinated, scar tissue or incision in the vastus lateralis region,

Who the study is looking for

  • healthy term neonates
  • born at 38-42 weeks gestational week,
  • birth weight 2500-4400 g,
  • 5th minute APGAR score above 6,
  • in stable health,
  • able to carry out vital activities without support,
  • babies ordered Hepatitis B vaccine by the doctor

Age in the registry: 38 weeks to 42 weeks · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul Medeniyet University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.